Inventor
AAGAARD CLAUS
DK10 patents
⚠️ This page may combine multiple inventors who share the name “AAGAARD CLAUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
STATENS SERUMINSTITUT
6 patentsUS8703151B2Apr 22, 2014
Tuberculosis vaccines comprising antigens expressed during the latent infection phase
STATENS SERUMINSTITUT7 citations81
US10004793B2Jun 26, 2018
M.tuberculosis vaccines
STATENS SERUMINSTITUT3 citations65
US7968105B2Jun 28, 2011
Tuberculosis vaccines comprising antigens expressed during the latent infection phase
STATENS SERUMINSTITUT2 citations60
US9526773B2Dec 27, 2016
M. tuberculosis vaccines
STATENS SERUMINSTITUT2 citations59
USRE46583EOct 24, 2017
Vaccines comprising TB10.4
STATENS SERUMINSTITUT0 citations49
US10641770B2May 5, 2020
Diagnostic reagents for improved in vivo or in vitro cell-mediated immunological diagnosis of tuberculosis
STATENS SERUMINSTITUT0 citations31
AAGAARD CLAUS
3 patentsUS8293250B2Oct 23, 2012
Tuberculosis vaccines comprising antigens expressed during the latent infection phase
AAGAARD CLAUS0 citations47
US8101193B2Jan 24, 2012
Tuberculosis vaccines comprising antigens expressed during the latent infection phase
AAGAARD CLAUS0 citations47
US8105614B2Jan 31, 2012
Expanding the T cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails
AAGAARD CLAUS0 citations46